Categories AlphaGraphs, Earnings, Health Care

Trxade Health (MEDS) reports 20% growth in Q4 revenue; results beat estimates

Trxade Health Inc (NASDAQ: MEDS) Monday reported a narrower net loss for the fourth quarter of 2021 as the pharmaceutical services company’s revenues increased 20%.

Trxade Q4 2021 earnings infographic

Fourth-quarter revenues increased 19.7% year-over-year to $2.4 million and came in above analysts’ estimates. The company added 175 registered members during the three-month period.

Trxade reported a net loss of $0.8 million or $0.10 per share for the fourth quarter, which marked an improvement from the $2.3 million or $0.29 per share loss reported in the year-ago quarter. The bottom line also beat analysts’ estimates.

Check this space to read management/analysts’ comments on Trxade’s Q4 2021 results

Shares of Trxade closed Monday’s trading higher and continued to gain in the extended session, soon after the earnings announcement. The stock has lost about 55% in the past six months.

Prior Performance

  • Trxade Health Q3 2021 earnings
  • Trxade Health Q2 2021 earnings
  • Trxade Q1 2021 earnings
  • Trxade Q4 2020 earnings

Most Popular

V Earnings: Key quarterly highlights from Visa’s Q1 2023 financial results

Visa Inc. (NYSE: V) reported first quarter 2023 earnings results today. Net revenues grew 12% year-over-year to $7.9 billion. GAAP net income rose 6% to $4.2 billion while EPS grew

Earnings: Highlights of Intel’s (INTC) Q4 2022 financial results

Intel Corporation (NASDAQ: INTC) Thursday reported a decline in adjusted earnings and revenues for the fourth quarter. The semiconductor giant also provided guidance for the first quarter of 2023. Fourth-quarter

McCormick (MKC) expects to drive sales growth in 2023 through pricing actions and cost savings

Shares of McCormick & Company Inc. (NYSE: MKC) were down over 5% on Thursday after the company missed expectations on its fourth quarter 2022 results and provided a lower-than-expected earnings

Add Comment
Viewing Highlight